These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 11334865)

  • 1. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
    Yan QS; Yan SE
    Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis.
    Yan QS; Zheng SZ; Yan SE
    Brain Res; 2004 Sep; 1021(1):82-91. PubMed ID: 15328035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS; Zheng SZ; Feng MJ; Yan SE
    Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices.
    Yan QS; Yan SE
    J Neurochem; 2001 Nov; 79(4):914-22. PubMed ID: 11723184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.
    O'Dell LE; Parsons LH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):711-9. PubMed ID: 15226384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
    Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
    Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release.
    Nisell M; Nomikos GG; Svensson TH
    Pharmacol Toxicol; 1994 Dec; 75(6):348-52. PubMed ID: 7534921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
    Fu Y; Matta SG; Gao W; Sharp BM
    Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Brain Res; 2000 May; 865(1):85-90. PubMed ID: 10814735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
    You ZB; Chen YQ; Wise RA
    Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.
    Ericson M; Molander A; Löf E; Engel JA; Söderpalm B
    Eur J Pharmacol; 2003 Apr; 467(1-3):85-93. PubMed ID: 12706460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis.
    Murphy NP; Maidment NT
    J Neurochem; 1999 Jul; 73(1):179-86. PubMed ID: 10386969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of systemic 5-HT(1B) receptor compounds on ventral tegmental area intracranial self-stimulation thresholds in rats.
    Hayes DJ; Graham DA; Greenshaw AJ
    Eur J Pharmacol; 2009 Feb; 604(1-3):74-8. PubMed ID: 19135047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission.
    Yan QS
    Brain Res Bull; 2000 Jan; 51(1):75-81. PubMed ID: 10654584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of escitalopram and a 5-HT(₁A) receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT(₂C) receptor stimulation; suggestive of antipsychotic potential.
    Hovelsø N; Sager TN; Mørk A
    Pharmacol Biochem Behav; 2011 Jan; 97(3):479-85. PubMed ID: 20937301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation in the activity of the 5-HT(1B) autoreceptor in the region of the suprachiasmatic nucleus, measured by microdialysis in the conscious freely-moving rat.
    Garabette ML; Martin KF; Redfern PH
    Br J Pharmacol; 2000 Dec; 131(8):1569-76. PubMed ID: 11139433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis.
    Bentué-Ferrer D; Reymann JM; Rousselle JC; Massot O; Bourin M; Allain H; Fillion G
    Eur J Pharmacol; 1998 Oct; 358(2):129-37. PubMed ID: 9808261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.